Similarly, high levels of serum CCL2 and CCL5 were observed in BC patients in contrast to healthy donors, and metastatic BC patients had higher levels of serum CCL2 and CCL5 than those without metastasis (Figure 8F-G). This evidence concerns the gene CCL2 and breast cancer.